Articles From: Boston Properties Expands Deployment of EnerNOC's Energy Intelligence Software Platform to MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference


ATHENS, Greece, Sept.
Sign-up for TOP Ships Inc. Announces Increase of Independent Directors investment picks
- Accelerates Adoption through Complementary Sales Channels - Enhances 3DS' Metal Printing and Manufacturing Service Capabilities - Expands 3DS' IP, Technology Platform and Medical Device Productions - Extends 3DS' Direct Metal Printer Expertise and Product Portfolio - Expected to be Immediately Accretive to Cash Generation ROCK HILL, S.C., Sept.
Sign-up for Photo Release -- 3D Systems Acquires LayerWise, Extending Its Global Leadership in Advanced Metal 3D Printing, On-Demand Parts Manufacturing Services and Personalized Medical Devices investment picks
2014/9/3
ATHENS, Greece, Sept.
Sign-up for STEALTHGAS INC. Announces New Vessel Acquisitions, and New Employment for Its Vessels investment picks
SAN DIEGO, Sept.
Sign-up for Biocept Strengthens Its Circulating Tumor Cell IP Position in Europe investment picks
HILLSBORO, Ore., Sept.
Sign-up for FEI Releases New Helios NanoLab G3 DualBeam investment picks
HILLSBORO, Ore., Sept.
Sign-up for FEI Announces Teneo VS for 3D Volume Imaging of Cells and Tissues investment picks
DURHAM, N.C., Sept.
Sign-up for Chimerix's Brincidofovir Has in Vitro Activity Against Ebola investment picks
DANVERS, Mass., Sept.
Sign-up for Abiomed to Present at the Morgan Stanley Global Healthcare Conference 2014 investment picks
LAVAL, Quebec, Sept.
Sign-up for Neptune to Present at Rodman & Renshaw Global Investment Conference investment picks
PORTLAND, Ore., Sept.
Sign-up for Galena Biopharma to Present at the Rodman & Renshaw 16th Annual Global Investment Conference investment picks
2014/9/3
ST. LOUIS, Sept.
Sign-up for Research From Equifax Workforce Solutions Explores Onboarding Best Practices for Higher Education investment picks
The randomized, double-blind, placebo-controlled, parallel group Phase III study with RHB-102 (the GUARD study) will enroll 320 acute gastroenteritis patients in the U.S. Acute gastroenteritis is an inflammation of the gastrointestinal tract causing nausea and vomiting, with a potential worldwide market estimated to exceed $650 million If approved for marketing by the FDA, RHB-102 is expected to be the first-ever 5-HT3 antagonist drug indicated for acute gastroenteritis Dr.
Sign-up for RedHill Biopharma Initiates Phase III Study of RHB-102 for Gastroenteritis investment picks
RESEARCH TRIANGLE PARK, N.C., Sept.
Sign-up for BioCryst to Present at Rodman & Renshaw Conference investment picks
FORT WORTH, Texas, Sept.
Sign-up for ALLIED ELECTRONICS EARNS AS9120A CERTIFICATION investment picks
2014/9/3
NEWTON, Mass., Sept.
Sign-up for Responding to Reviews Online Drives Booking Inquiries, TripAdvisor Study Reveals investment picks
HORSHAM, Pa., Sept.
Sign-up for Toll Brothers Reports FY 2014 3rd Qtr and 9 Month Results investment picks
WINTER SPRINGS, Fla., Sept.
Sign-up for IRADIMED CORPORATION Announces Receipt of FDA Warning Letter investment picks
TORRANCE, Calif., Sept.
Sign-up for Farmer Bros. Co. to Report Fourth Quarter and Year End Fiscal 2014 Results on September 9, 2014 investment picks
MARTINSVILLE, Va., Sept.
Sign-up for Hooker Furniture to Host Second Quarter Earnings Call September 10 investment picks
VALENCIA, Calif., Sept.
Sign-up for MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Boston Properties Expands Deployment of EnerNOC's Energy Intelligence Software Platform to MannKind Corporation to Present at Morgan Stanley Global Healthcare Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent